Frontiers in Endocrinology

Liraglutide use in congenital generalized lipodystrophy: glycemic and metabolic outcomes

By Jéssica S. Araújo, Natalia P Boris, Fábia Karine de M. Lopes, Renan M. Montenegro Junior

Figure 1 from Frontiers in Endocrinology — Figure 1. Araújo et al.

Trial in 8 peopleInterventions

Case series, declared ties to: Brazilian Hospital Services Company

The paper

Jéssica S. Araújo, Natalia P Boris, Fábia Karine de M. Lopes, Renan M. Montenegro Junior

Universidade Federal do Ceará

Frontiers in Endocrinology, 22 Sep 2026

doi.org/10.3389/fendo.2026.1912138 PubMed 42840192

Frontiers in Endocrinology4 Oct 2026
Six blood metabolites distinguish metabolic health in obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Frontiers in Aging3 Oct 2026
Lifestyle modification reduces phenotypic age in adults with prediabetes